Report Tools

Merck & Co., Inc. - SWOT, Strategy and Corporate Finance Report

Published: July 2013 · Publisher: MarketLine
Merck & Co., Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, etc.
Report Type Company Profiles
Language English
Format Electronic (PDF)
Pages79
Frequency Updated Annually
Availability Will be emailed within 1 business day
Reference No. 0109-6243
Price € 129,00
Options
  • Description
  • Table of Contents
  • Ask a Question
Merck & Co., Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.

Features:

- Detailed information on Merck & Co., Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Merck & Co., Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Merck & Co., Inc. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Merck & Co., Inc.
- Intelligence on Merck & Co., Inc.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Merck & Co., Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Merck & Co. (or ‘the company’), known as Merck Sharp & Dohme (MSD) outside the US and Canada, is one of the leading healthcare companies in the world. The company is engaged in the research, development, manufacture and marketing of prescription pharmaceuticals, vaccines, biologic therapies, and consumer care and animal health products. It operates in more than 140 countries. Merck & Co. is headquartered in Whitehouse Station, New Jersey, and employed about 83,000 people as of December 31, 2012. The company recorded revenues of $47,267 million during the financial year ended December 2012 (FY2012), a decrease of 1.6% over FY2011. The operating profit of the company was $8,739 million in FY2012, an increase of 19.2% over FY2011. The net profit was $6,168 million in FY2012, a decrease of 1.7% over FY2011.

Reasons to Purchase:

- Gain understanding of Merck & Co., Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Merck & Co., Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Merck & Co., Inc.’s business structure, strategy and prospects

Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Company Snapshot
Merck & Co., Inc.: Company Overview
Merck & Co., Inc.: Overview and Key Facts
Merck & Co., Inc.: Overview
Merck & Co., Inc.: Key Facts
Merck & Co., Inc.: Key Employees
Merck & Co., Inc.: Key Employee Biographies
Merck & Co., Inc.: Major Products and Services
Merck & Co., Inc.: Company History
Merck & Co., Inc.: Management Statement
Merck & Co., Inc.: Locations and Subsidiaries
Merck & Co., Inc.: Key Competitors
Merck & Co., Inc.: Company Analysis
Merck & Co., Inc.: Business Description
Merck & Co., Inc.: SWOT Analysis
Merck & Co., Inc.: SWOT Overview
Merck & Co., Inc.: Strengths
Merck & Co., Inc.: Weaknesses
Merck & Co., Inc.: Opportunities
Merck & Co., Inc.: Threats
Merck & Co., Inc.: Financial Analysis
Merck & Co., Inc.: Financial Overview
Merck & Co., Inc.: Five Year Company Financials
Merck & Co., Inc.: Key Income Statement Data
Merck & Co., Inc.: Key Balance Sheet Data
Merck & Co., Inc.: Key Cash Flow Data
Merck & Co., Inc.: Key Market Data
Merck & Co., Inc.: Valuation Ratios
Merck & Co., Inc.: Profitability Ratios
Merck & Co., Inc.: Management Efficiency Ratios
Merck & Co., Inc.: Financial Strength Ratios
Merck & Co., Inc.: Operational Efficiency Ratios
Merck & Co., Inc.: Others
Merck & Co., Inc.: Corporate Financial Deals Activity
Merck & Co., Inc.: Financial Deals Overview
Merck & Co., Inc.: Targets and Partners
Merck & Co., Inc.: Top Deals 2009 - 2013YTD*
Merck & Co., Inc.: Advisors
Merck & Co., Inc.: Top Legal Advisors
Merck & Co., Inc.: Top Financial Advisors
Merck & Co., Inc.: Mergers and Acquisitions
Merck & Co., Inc.: Corporate Venturing
Merck & Co., Inc.: Partnership
Merck & Co., Inc.: Divestments
Merck & Co., Inc.: Recent Developments
Merck & Co., Inc.: News and Events Summary
Merck & Co., Inc.: Business Expansion
Merck & Co., Inc.: Contracts
Merck & Co., Inc.: Corporate Governance
Merck & Co., Inc.: Financial Deals
Merck & Co., Inc.: Financial Performance
Merck & Co., Inc.: Regulatory and Legal Events
Merck & Co., Inc.: Research & Development
Appendix
Contact Us
Methodology
Definitions


List of Tables

Table 1: Merck & Co., Inc.: Key Facts
Table 2: Merck & Co., Inc.: Key Employees
Table 4: Merck & Co., Inc.: Key Competitors
Table 5: Merck & Co., Inc.: Key Income Statement Data
Table 6: Merck & Co., Inc.: Key Balance Sheet Data
Table 7: Merck & Co., Inc.: Key Cash Flow Data
Table 8: Merck & Co., Inc.: Key Market Data
Table 9: Merck & Co., Inc.: Key Growth Ratios
Table 10: Merck & Co., Inc.: Valuation Ratios
Table 11: Merck & Co., Inc.: Profitability Ratios
Table 12: Merck & Co., Inc.: Management Efficiency Ratios
Table 13: Merck & Co., Inc.: Financial Strength Ratios
Table 14: Merck & Co., Inc.: Operational Efficiency Ratios
Table 15: Merck & Co., Inc.: Others
Table 16: Merck & Co., Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 17: Merck & Co., Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 18: Merck & Co., Inc.: M&A Average Deal Size - Value (US$m)
Table 19: Merck & Co., Inc.: Targets and Partners
Table 20: Merck & Co., Inc.: Top Deals 2009 - 2013YTD*
Table 21: Merck & Co., Inc.: Legal Advisor Ranking by Value (US$m)
Table 22: Merck & Co., Inc.: Financial Advisor Ranking by Value (US$m)
Table 23: Merck & Co., Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Table 24: Merck & Co., Inc.: M&A Activity by Geography (2009 - YTD*2013)
Table 25: Merck & Co., Inc.: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Table 26: Merck & Co., Inc.: Corporate Venturing by Geography (2009 - YTD*2013)
Table 27: Merck & Co., Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 28: Merck & Co., Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 29: Merck & Co., Inc.: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 30: Merck & Co., Inc.: Divestments by Geography (2009 - YTD*2013)
Table 31: Merck & Co., Inc.: News and Events Summary
Table 32: Merck & Co., Inc.: Business Expansion
Table 33: Merck & Co., Inc.: Contracts
Table 34: Merck & Co., Inc.: Corporate Governance
Table 35: Merck & Co., Inc.: Financial Deals
Table 36: Merck & Co., Inc.: Financial Performance
Table 37: Merck & Co., Inc.: Regulatory and Legal Events
Table 38: Merck & Co., Inc.: Research & Development

List of Figures

Figure 1: Merck & Co., Inc.: Revenue to Net Income (2008-2012)
Figure 2: Merck & Co., Inc.: Revenue/Employee to Net Income/Employee (2008-2012)
Figure 3: Merck & Co., Inc.: Current Assets to Current Liabilities (2008-2012)
Figure 4: Merck & Co., Inc.: Assets, Liabilities to Total Equity (2008-2012)
Figure 5: Merck & Co., Inc.: Free Cash Flow to Cash from Operating Activities (2008-2012)
Figure 6: Merck & Co., Inc.: Net Change in Cash (2008-2012)
Figure 7: Merck & Co., Inc.: Market Capitalization to Year-end Share Price (2008-2012)
Figure 8: Merck & Co., Inc.: Enterprise Value (2008-2012)
Figure 9: Merck & Co., Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 10: Merck & Co., Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 11: Merck & Co., Inc.: M&A Average Deal Size - Value (US$m)
Figure 12: Merck & Co., Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 13: Merck & Co., Inc.: M&A Activity by Geography (2009 - YTD*2013)
Figure 14: Merck & Co., Inc.: Corporate Venturing Volume and Value Trend (2009 - YTD*2013)
Figure 15: Merck & Co., Inc.: Corporate Venturing by Geography (2009 - YTD*2013)
Figure 16: Merck & Co., Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Figure 17: Merck & Co., Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Figure 18: Merck & Co., Inc.: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 19: Merck & Co., Inc.: Divestments by Geography (2009 - YTD*2013)
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.